Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jun 1;99(11):2616–2624. doi: 10.1172/JCI119450

Expression of bacterial superantigen genes in mice induces localized mononuclear cell inflammatory responses.

S W Dow 1, T A Potter 1
PMCID: PMC508107  PMID: 9169491

Abstract

Bacterial superantigens are potent T cell activators, and superantigen proteins have been injected into mice and other animals to study T cell responses in vivo. When superantigen proteins are injected, however, the T cell stimulatory effects cannot be confined to specific tissues. Therefore, to target superantigen expression to specific tissues, we used gene transfer techniques to express bacterial superantigen genes in mammalian cells in vitro and in tissues in vivo. Murine, human, and canine cells transfected with superantigen genes in vitro all produced superantigen proteins both intracellularly and extracellularly, as assessed by bioassay, immunocytochemistry, and antigen ELISA. Superantigens produced by transfected eukaryotic cells retained their biologic specificity for T cell receptor binding. Intramuscular injection of superantigen plasmid DNA in vivo induced an intense intramuscular mononuclear cell infiltrate, an effect that could not be reproduced by intramuscular injection of superantigen protein. Intradermal and intravenous injection of superantigen DNA induced cutaneous and intrapulmonary mononuclear cell inflammatory responses, respectively. Thus, superantigen genes can be expressed by mammalian cells in vivo. Superantigen gene therapy represents a novel method of targeting localized T cell inflammatory reactions, with potential application to treatment of cancer and certain infectious diseases.

Full Text

The Full Text of this article is available as a PDF (647.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlsson R., Fischer H., Sjögren H. O. Binding of staphylococcal enterotoxin A to accessory cells is a requirement for its ability to activate human T cells. J Immunol. 1988 Apr 15;140(8):2484–2488. [PubMed] [Google Scholar]
  2. Choi Y. W., Herman A., DiGiusto D., Wade T., Marrack P., Kappler J. Residues of the variable region of the T-cell-receptor beta-chain that interact with S. aureus toxin superantigens. Nature. 1990 Aug 2;346(6283):471–473. doi: 10.1038/346471a0. [DOI] [PubMed] [Google Scholar]
  3. Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deresiewicz R. L., Flaxenburg J. A., Chan M., Finberg R. W., Kasper D. L. Intracellular expression of toxic shock syndrome toxin 1 in Saccharomyces cerevisiae. Infect Immun. 1994 Jun;62(6):2202–2207. doi: 10.1128/iai.62.6.2202-2207.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dohlsten M., Abrahmsén L., Björk P., Lando P. A., Hedlund G., Forsberg G., Brodin T., Gascoigne N. R., Förberg C., Lind P. Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8945–8949. doi: 10.1073/pnas.91.19.8945. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fleischer B., Schrezenmeier H. T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med. 1988 May 1;167(5):1697–1707. doi: 10.1084/jem.167.5.1697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fraser J. D. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR. Nature. 1989 May 18;339(6221):221–223. doi: 10.1038/339221a0. [DOI] [PubMed] [Google Scholar]
  8. Gascoigne N. R., Ames K. T. Direct binding of secreted T-cell receptor beta chain to superantigen associated with class II major histocompatibility complex protein. Proc Natl Acad Sci U S A. 1991 Jan 15;88(2):613–616. doi: 10.1073/pnas.88.2.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gelfand E. W., Saloga J., Lack G. Modification of immediate hypersensitivity responses by staphylococcal enterotoxin B. J Clin Immunol. 1995 Nov;15(6 Suppl):37S–41S. doi: 10.1007/BF01540892. [DOI] [PubMed] [Google Scholar]
  10. Hamad A. R., Herman A., Marrack P., Kappler J. W. Monoclonal antibodies defining functional sites on the toxin superantigen staphylococcal enterotoxin B. J Exp Med. 1994 Aug 1;180(2):615–621. doi: 10.1084/jem.180.2.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Herman A., Croteau G., Sekaly R. P., Kappler J., Marrack P. HLA-DR alleles differ in their ability to present staphylococcal enterotoxins to T cells. J Exp Med. 1990 Sep 1;172(3):709–717. doi: 10.1084/jem.172.3.709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Herman A., Kappler J. W., Marrack P., Pullen A. M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol. 1991;9:745–772. doi: 10.1146/annurev.iy.09.040191.003525. [DOI] [PubMed] [Google Scholar]
  13. Herman A., Labrecque N., Thibodeau J., Marrack P., Kappler J. W., Sekaly R. P. Identification of the staphylococcal enterotoxin A superantigen binding site in the beta 1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9954–9958. doi: 10.1073/pnas.88.22.9954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Janeway C. A., Jr, Yagi J., Conrad P. J., Katz M. E., Jones B., Vroegop S., Buxser S. T-cell responses to Mls and to bacterial proteins that mimic its behavior. Immunol Rev. 1989 Feb;107:61–88. doi: 10.1111/j.1600-065x.1989.tb00003.x. [DOI] [PubMed] [Google Scholar]
  15. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
  16. Kawamura T., Nagata M., Utsugi T., Yoon J. W. Prevention of autoimmune type I diabetes by CD4+ suppressor T cells in superantigen-treated non-obese diabetic mice. J Immunol. 1993 Oct 15;151(8):4362–4370. [PubMed] [Google Scholar]
  17. Kotzin B. L., Leung D. Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166. doi: 10.1016/s0065-2776(08)60534-9. [DOI] [PubMed] [Google Scholar]
  18. Langford M. P., Stanton G. J., Johnson H. M. Biological effects of staphylococcal enterotoxin A on human peripheral lymphocytes. Infect Immun. 1978 Oct;22(1):62–68. doi: 10.1128/iai.22.1.62-68.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 Jun 1;248(4959):1066–1066. [PubMed] [Google Scholar]
  20. Micusan V. V., Thibodeau J. Superantigens of microbial origin. Semin Immunol. 1993 Feb;5(1):3–11. doi: 10.1006/smim.1993.1002. [DOI] [PubMed] [Google Scholar]
  21. Miethke T., Wahl C., Heeg K., Echtenacher B., Krammer P. H., Wagner H. T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med. 1992 Jan 1;175(1):91–98. doi: 10.1084/jem.175.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Newell K. A., Ellenhorn J. D., Bruce D. S., Bluestone J. A. In vivo T-cell activation by staphylococcal enterotoxin B prevents outgrowth of a malignant tumor. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1074–1078. doi: 10.1073/pnas.88.3.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ochi A., Migita K., Xu J., Siminovitch K. In vivo tumor immunotherapy by a bacterial superantigen. J Immunol. 1993 Sep 15;151(6):3180–3186. [PubMed] [Google Scholar]
  24. Ochi A., Yuh K., Migita K., Kawabe Y. Effects of staphylococcal toxins on T-cell activity in vivo. Chem Immunol. 1992;55:115–136. [PubMed] [Google Scholar]
  25. Panina-Bordignon P., Fu X. T., Lanzavecchia A., Karr R. W. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen. J Exp Med. 1992 Dec 1;176(6):1779–1784. doi: 10.1084/jem.176.6.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peavy D. L., Adler W. H., Smith R. T. The mitogenic effects of endotoxin and staphylococcal enterotoxin B on mouse spleen cells and human peripheral lymphocytes. J Immunol. 1970 Dec;105(6):1453–1458. [PubMed] [Google Scholar]
  27. Plautz G. E., Yang Z. Y., Wu B. Y., Gao X., Huang L., Nabel G. J. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc Natl Acad Sci U S A. 1993 May 15;90(10):4645–4649. doi: 10.1073/pnas.90.10.4645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Raz E., Carson D. A., Parker S. E., Parr T. B., Abai A. M., Aichinger G., Gromkowski S. H., Singh M., Lew D., Yankauckas M. A. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9519–9523. doi: 10.1073/pnas.91.20.9519. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Rott O., Wekerle H., Fleischer B. Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol. 1992 Mar;4(3):347–353. doi: 10.1093/intimm/4.3.347. [DOI] [PubMed] [Google Scholar]
  30. Saloga J., Leung D. Y., Reardon C., Giorno R. C., Born W., Gelfand E. W. Cutaneous exposure to the superantigen staphylococcal enterotoxin B elicits a T-cell-dependent inflammatory response. J Invest Dermatol. 1996 May;106(5):982–988. doi: 10.1111/1523-1747.ep12338479. [DOI] [PubMed] [Google Scholar]
  31. Schiffenbauer J., Johnson H. M., Butfiloski E. J., Wegrzyn L., Soos J. M. Staphylococcal enterotoxins can reactivate experimental allergic encephalomyelitis. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8543–8546. doi: 10.1073/pnas.90.18.8543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scholl P. R., Diez A., Karr R., Sekaly R. P., Trowsdale J., Geha R. S. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules. J Immunol. 1990 Jan 1;144(1):226–230. [PubMed] [Google Scholar]
  33. Schwab J. H., Brown R. R., Anderle S. K., Schlievert P. M. Superantigen can reactivate bacterial cell wall-induced arthritis. J Immunol. 1993 May 1;150(9):4151–4159. [PubMed] [Google Scholar]
  34. Solodin I., Brown C. S., Bruno M. S., Chow C. Y., Jang E. H., Debs R. J., Heath T. D. A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry. 1995 Oct 17;34(41):13537–13544. doi: 10.1021/bi00041a033. [DOI] [PubMed] [Google Scholar]
  35. Thierry A. R., Lunardi-Iskandar Y., Bryant J. L., Rabinovich P., Gallo R. C., Mahan L. C. Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9742–9746. doi: 10.1073/pnas.92.21.9742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993 Mar 19;259(5102):1745–1749. doi: 10.1126/science.8456302. [DOI] [PubMed] [Google Scholar]
  37. White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
  38. Zhu N., Liggitt D., Liu Y., Debs R. Systemic gene expression after intravenous DNA delivery into adult mice. Science. 1993 Jul 9;261(5118):209–211. doi: 10.1126/science.7687073. [DOI] [PubMed] [Google Scholar]
  39. Zlotnik A., Shimonkevitz R. P., Gefter M. L., Kappler J., Marrack P. Characterization of the gamma-interferon-mediated induction of antigen-presenting ability in P388D1 cells. J Immunol. 1983 Dec;131(6):2814–2820. [PubMed] [Google Scholar]
  40. de Azavedo J. C. Animal models for toxic shock syndrome: overview. Rev Infect Dis. 1989 Jan-Feb;11 (Suppl 1):S205–S209. doi: 10.1093/clinids/11.supplement_1.s205. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES